Jennison Associates
PETX

Jennison Associates’s Aratana Therapeutics, Inc. PETX Stock Holding History

Jennison Associates’s Portfolio PETX Stock Details PETX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-975,369
Closed -$5.17M – 675
2017
Q1 		$5.17M Sell
975,369
-171,558
-15% -$1.16M 0.01% 510
2016
Q4 		$8.23M Sell
1,146,927
-75,080
-6% -$607K 0.01% 492
2016
Q3 		$11.4M Sell
1,222,007
-1,637,927
-57% -$13.6M 0.01% 463
2016
Q2 		$18.1M Sell
2,859,934
-1,176,191
-29% -$7.56M 0.02% 412
2016
Q1 		$22.3M Buy
4,036,125
+17,690
+0.4% +$66.5K 0.02% 390
2015
Q4 		$22.4M Sell
4,018,435
-127,765
-3% -$844K 0.02% 409
2015
Q3 		$35.1M Buy
4,146,200
+714,413
+21% +$12.1M 0.04% 358
2015
Q2 		$51.9M Buy
3,431,787
+311,738
+10% +$4.5M 0.05% 332
2015
Q1 		$50M Sell
3,120,049
-13,659
-0.4% -$243K 0.05% 329
2014
Q4 		$55.8M Buy
3,133,708
+57,943
+2% +$722K 0.05% 307
2014
Q3 		$30.9M Buy
3,075,765
+638,761
+26% +$7.74M 0.03% 397
2014
Q2 		$38M Buy
2,437,004
+529,147
+28% +$7.5M 0.04% 365
2014
Q1 		$35.4M Buy
1,907,857
+498,721
+35% +$9.99M 0.03% 380
2013
Q4 		$26.9M Buy
1,409,136
+979,183
+228% +$19.9M 0.03% 414
2013
Q3 		$7.03M Buy
429,953
+4,953
+1% +$52K 0.01% 492
2013
Q2 		$3.21M Buy
+425,000
New +$3.36M ﹤0.01% 506

Other funds holding PETX

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Jennison Associates's PETX Position: Q2 2017 in Review

Jennison Associates sold out of Aratana Therapeutics, Inc. (PETX) in Q2 2017, closing a stake of 975,369 shares — an estimated $5.17M sold.

Jennison Associates first reported a position in PETX in Q2 2013 and held it in 16 quarters. The position peaked at $55.8M in Q4 2014. 105 funds tracked by Wall St. Rank hold PETX as of Q2 2017.

  • Jennison Associates reported no remaining Aratana Therapeutics, Inc. position as of Q2 2017 after selling out during the quarter.
  • Jennison Associates sold 975,369 Aratana Therapeutics, Inc. shares in Q2 2017, an estimated $5.17M.
  • Jennison Associates first reported a position in Aratana Therapeutics, Inc. in Q2 2013 and held it in 16 quarters.
  • Jennison Associates's Aratana Therapeutics, Inc. position peaked at $55.8M in Q4 2014.
  • 105 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q2 2017.

Based on Jennison Associates's 13F filing for Q2 2017, filed 4 Aug 2017.